Roszdravnadzor suspends two batches of Armenian-made Pyridoxine
November 17 2026, 13:15
Roszdravnadzor has halted the circulation of two batches of the Armenian-made drug Pyridoxine because they did not meet shelf-life requirements.
The restrictions apply to batches 340925 and 401225. Samples from these batches were taken for testing at Kadyy District Hospital in Kostroma Region and at the N. S. Karpovich Krasnoyarsk Interdistrict Clinical Emergency Hospital, respectively.
The samples were tested as part of selective quality control by specialists from the Krasnoyarsk and Yaroslavl branches of the Information and Methodological Center for Expert Evaluation, Record and Analysis of Circulation of Medical Products (IMCEUAOSMP), a federal state budgetary institution under Roszdravnadzor. Laboratory tests showed that both batches failed to meet the established shelf-life standards.